NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Testicular cancer: Does routine screening for men aged 16 years and older lead to better treatment outcomes? IQWiG Reports – Commission No. HT18-01 [Internet] Cologne (Germany): Institute for Quality and Efficiency in Health Care (IQWiG); 2021 Apr 14.
Testicular cancer: Does routine screening for men aged 16 years and older lead to better treatment outcomes? IQWiG Reports – Commission No. HT18-01 [Internet]
Show details4.1. Results of the comprehensive information retrieval
The information retrieval found neither randomized controlled studies nor nonrandomized prospective, comparative interventional studies with concurrent control group to answer the research question of the benefit assessment.
The search strategies for bibliographic databases and trial registries are found in the appendix. The most recent search was conducted on 7 November 2018. No ongoing studies were identified. The most recent search was conducted on 15 January 2019.
4.2. Results of the benefit assessment
Since no suitable studies were found, no conclusions can be drawn on the benefits and harms of testicular cancer screening. There is no hint of (greater) benefit or (greater) harm.
- Results: Benefit assessment - Testicular cancerResults: Benefit assessment - Testicular cancer
Your browsing activity is empty.
Activity recording is turned off.
See more...